Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review.

@article{Wissner2012CatheterAO,
  title={Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review.},
  author={E. Wissner and W. Stevenson and K. Kuck},
  journal={European heart journal},
  year={2012},
  volume={33 12},
  pages={
          1440-50
        }
}
  • E. Wissner, W. Stevenson, K. Kuck
  • Published 2012
  • Medicine
  • European heart journal
  • According to the current guidelines, patients with ischaemic cardiomyopathy (ICM) or non-ischaemic cardiomyopathy (NICM) at risk for sudden cardiac death should undergo implantation of an implantable cardioverter-defibrillator (ICD). Although ICDs effectively terminate ventricular arrhythmias, the arrhythmogenic substrate remains unchanged or may progress over time, resulting in recurrent ICD shocks. Defibrillator shocks increase mortality and worsen quality of life. Evidence from two… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    This is a prospective multicenter randomized open-label study aiming to assess whether endocardial or endocardial-epicardial ablation is superior to the standard approach (i.e… Expand
    ConditionsVentricular Tachycardia
    InterventionDrug, Procedure
    EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.
    • 200
    • PDF
    EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.
    • 127
    • PDF
    Cellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress
    • 40
    • Highly Influenced
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 76 REFERENCES
    Prognostic importance of defibrillator shocks in patients with heart failure.
    • 1,147
    • PDF